Carcinoid Syndrome
Lanreotide Effectively Controls Diarrhea, Flushing in Neuroendocrine Tumors
October 23, 2017Results of the double-blinded and initial open-label phases of the ELECT Study demonstrate the effectiveness of lanreotide in controlling diarrhea and flushing in patients with NETs presenting with carcinoid syndrome.
Cost of Care Significantly Increased With Carcinoid Syndrome in NETs
September 25, 2017Development of carcinoid syndrome has a profound effect on cost of care for patients with neuroendocrine tumors (NETs).
Efficacy of Octreotide LAR, Lanreotide in Management of Carcinoid Tumors
September 22, 2017Benefits of long-acting, repeatable octreotide and lanreotide in neuroendocrine tumors, formerly known as carcinoid tumors, are similar.
FDA Approves Supplemental Indication for Lanreotide Depot for Carcinoid Syndrome
September 19, 2017Patients who receieved lanreotide depot had a significantly lower percentage of days when rescue octreotide was used compared with placebo.
Lanreotide Eases Carcinoid Syndrome Symptoms in All Patients
June 04, 2017Lanreotide decreased the proportion of days patients had flushing and diarrhea compared with placebo, even in patients previously responsive to rescue therapy with octreotide.
Lutetium-177 Dotatate Improves PFS in Advanced Midgut Carcinoid Tumors
January 17, 2017Findings are presented from an open-label NETTER-1 clinical trial evaluating the efficacy and safety of 177Lu-Dotatate in patients with advanced midgut neuroendocrine tumors who have experienced disease progression during first-line treatment with a somatostatin analogue.
Sign Up for Free e-newsletters
ONA Articles
- Steering Patients Toward Reliable Internet Resources
- ADT May Up Risk for Heart Failure in Prostate Cancer Patients
- PFS, OS Improved With Sequential Rituximab/Bendamustine, Rituximab/Cytarabine in Untreated Mantle Cell Lymphoma
- Patients, Physicians Do Not Recognize Fatigue the Same
- Alternative Medicine Beliefs: How Far Will Cancer Patients Go for Alternative Results?
- Counseling Patients on Oral Chemotherapy
- Smartphone App Improves Management of Cancer-Related Pain, Anxiety
- Steering Patients Toward Reliable Internet Resources
- Proscription on Antiperspirant Use During Radiotherapy: Does the Advice Still Apply?
- Lung Cancer-Specific Distress Screening Tool Not Needed But Has Potential Benefit
- Many Americans Unaware of the Promise of Personalized Medicine
- Alternative Medicine Beliefs: How Far Will Cancer Patients Go for Alternative Results?
- Steering Patients Toward Reliable Internet Resources
- Postmastectomy Breast Reconstruction Safe in Older Women With Breast Cancer
- CIPN in Breast Cancer: Do Subjective and Objective Measures Correlate?
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |